Penicillium marneffei is rarely pathogenic in humans. Most previously repor
ted cases of P. marneffei infection were from Southeast Asia where patients
were usually in an immunocompromised state due to human immunodeficiency v
irus (HIV) infection. The majority of the patients reported in Western coun
tries were immunocompromised by malignancy, especially Hodgkin's lymphoma.
In Taiwan, the first case of P. marneffei infection was reported in 1994 an
d involved an adult with HIV infection. We report a case of systemic P. mar
neffei infection in a child with common variable immunodeficiency (CVID). T
he patient, a 4-year, 5-month-old boy, had a 1-year history of oligoarthrit
is resembling juvenile rheumatoid arthritis (JRA). Ile developed a low grad
e fever (38 degrees C) and hepatosplenomegaly 1 month before admission to t
he hospital. Although cultures of synovial fluid obtained at the time of on
set of oligoarthritis did not grow any organisms, cultures of blood, bone m
arrow, synovial fluid, and lymph node biopsy samples taken during this admi
ssion were positive for P. marneffei. Further immunologic studies revealed
a profile characteristic of CVID. The fungal infection was finally eradicat
ed by combined therapy with amphotericin B. fluconazole, itraconazole, and
regular immunoglobulin replacement. This case reminds us that JRA or JRA-li
ke arthritis should be differentiated from septic arthritis caused by rare
pathogens in immunocompromised patients.